January 01, 2015 - MM&M - Medical Marketing and Media

Print Issue: January 01, 2015

Therapeutic Focus: Cardiovascular

Therapeutic Focus: Cardiovascular

The cardiovascular space has long ranked among the pharma industry’s most vibrant. Even by that standard, however, 2015 is shaping up as a blockbuster year, and PCSK9 inhibitors have a lot to do with projections. Estimates for their success could prove even better if they are shown to reduce cardiovascular event risk, as well. Joe Dysart explains

Communication Shakedown

Communication Shakedown

Long the only game in town, health insurers—many have observed—never mastered the art of customer service. But with a host of tech- and service-savvy upstarts making plays for “their” customers, the rules have changed. Sarah Mahoney examines how the new breed of insurers—who mix high tech with high touch—are trying to outflank the establishment

Private View: Norm Alger

Private View: Norm Alger

“Here are some examples of some elegant initiatives from some very smart people to put a substantial stake in the ground toward these rather monumental global [health] efforts.”